Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Guardian Pharmacy Services (GRDN) Income from Non-Controlling Interests (2023 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed Income from Non-Controlling Interests for 3 consecutive years, with $342000.0 as the latest value for Q4 2025.

  • Quarterly Income from Non-Controlling Interests rose 435.29% to $342000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$261000.0 through Dec 2025, down 101.61% year-over-year, with the annual reading at -$261000.0 for FY2025, 101.61% down from the prior year.
  • Income from Non-Controlling Interests hit $342000.0 in Q4 2025 for Guardian Pharmacy Services, up from -$225000.0 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $6.8 million in Q3 2024 to a low of -$225000.0 in Q3 2025.
  • Historically, Income from Non-Controlling Interests has averaged $2.3 million across 3 years, with a median of $1.4 million in 2023.
  • Biggest YoY gain for Income from Non-Controlling Interests was 435.29% in 2025; the steepest drop was 104.06% in 2025.
  • Year by year, Income from Non-Controlling Interests stood at $2.5 million in 2023, then plummeted by 104.01% to -$102000.0 in 2024, then skyrocketed by 435.29% to $342000.0 in 2025.
  • Business Quant data shows Income from Non-Controlling Interests for GRDN at $342000.0 in Q4 2025, -$225000.0 in Q3 2025, and -$203000.0 in Q2 2025.